| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Colorectal Neoplasms | D015179 | 10 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Familial Mediterranean Fever | D010505 | 12 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
alpha-artemisic acid
Alpha-artemisic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1126 references associated with alpha-artemisic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for alpha-artemisic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with alpha-artemisic acid
NCBI Entrez Crosslinks
All references with alpha-artemisic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Pongracz J and Lord JM | The lipoxygenase product 13-hydroxyoctadecadienoic acid (13-HODE) is a selective inhibitor of classical PKC isoenzymes. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10079174 |
| Fang X et al. | 13-(S)-hydroxyoctadecadienoic acid (13-HODE) incorporation and conversion to novel products by endothelial cells. | 1999 | J. Lipid Res. | pmid:10191294 |
| Friedrichs B et al. | 13-HPODE and 13-HODE modulate cytokine-induced expression of endothelial cell adhesion molecules differently. | 1999 | Biofactors | pmid:10221158 |
| Truitt A et al. | Antiplatelet effects of conjugated linoleic acid isomers. | 1999 | Biochim. Biophys. Acta | pmid:10320806 |
| Spindler S and Reddy RG | Effect of pH on enzyme immunoassay and analysis of urine. | 1998 | Am Clin Lab | pmid:10345154 |
| Sauer LA et al. | 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. | 1999 | Cancer Res. | pmid:10493526 |
| Blask DE et al. | Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. | 1999 | Cancer Res. | pmid:10493527 |
| Sakashita T et al. | Essential involvement of 12-lipoxygenase in regiospecific andstereospecific oxidation of low density lipoprotein by macrophages. | 1999 | Eur. J. Biochem. | pmid:10504415 |
| Shureiqi I et al. | Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. | 1999 | Carcinogenesis | pmid:10506115 |